Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.

OPB-171775

  Cat. No.:  DC60624   Featured
Chemical Structure
2131210-15-4
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86 21 58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
OPB-171775 represents a breakthrough in GIST treatment as a first-in-class, non-tyrosine kinase inhibitor (non-TKI) compound that demonstrates potent antitumor activity independent of KIT mutation status. Unlike conventional TKIs that target oncogenic kinases, OPB-171775 operates through an innovative mechanism by orchestrating a protein-protein interaction between phosphodiesterase 3A (PDE3A) and Schlafen 12 (SLFN12).
Cas No.: 2131210-15-4
Chemical Name: OPB-171775
Synonyms: (4R)-3-[2,3-difluoro-4-(2-hydroxy-2-methylpropoxy)phenyl]-4-methyl-4,5-dihydro-1H-pyridazin-6-one;(4R)-3-[2,3-difluoro-4-(2-hydroxy-2-methylpropoxy)phenyl]-4-methyl-4,5-dihydro-1H-pyridazin-6-one;GTPL13643;GTPL13643;GTPL13643;OPB-171775;OPB-171775;OPB-171775;EX-A9729;EX-A9729;EX-A9729;EX-A9729;OPB171775;OPB171775;OPB171775;OPB171775;Example 124 [US20190023662];Example 124 [US20190023662];Example 124 [US20190023662];Example 124 [US20190023662];SCHEMBL20607360;SCHEMBL20607360;SCHEMBL20607360;SCHEMBL20607360;HY-162730;HY-162730;HY-162730;2131210-15-4;2131210-15-4;HY-162730;2131210-15-4;2131210-15-4
SMILES: FC1C(=C(C=CC=1C1[C@H](C)CC(NN=1)=O)OCC(C)(C)O)F
Formula: C15H18F2N2O3
M.Wt: 312.31
Purity: 98%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
X